Current Treatment Strategies for Tricuspid Regurgitation

Mohammed Al-Hijji, Erin A. Fender, Abdallah El Sabbagh, David R. Holmes

Research output: Contribution to journalReview articlepeer-review

3 Scopus citations


Purpose of Review: Tricuspid regurgitation is common; however, recognition and diagnosis, clinical outcomes, and management strategies are poorly defined. Here, we will describe the etiology and natural history of tricuspid regurgitation (TR), evaluate existing surgical outcomes data, and review the evolving field of percutaneous interventions to treat TR. Recent Findings: Previously, the only definitive corrective therapy for TR was surgical valve repair or replacement which is associated with significant operative mortality. Advances in percutaneous valve repair techniques are now being translated to the tricuspid valve. These novel interventions may offer a lower-risk alternative treatment in patients at increased surgical risk. Summary: Significant TR adversely impacts survival. Surgery remains the only proven therapy for treatment of TR and may be underutilized due to mixed outcomes data. Early experience with percutaneous interventions is promising, but large clinical experience is lacking. Further study will be required before these therapies are introduced into broader clinical practice.

Original languageEnglish (US)
Article number106
JournalCurrent cardiology reports
Issue number11
StatePublished - Nov 1 2017


  • Percutaneous valve repair
  • Transcatheter valve replacement
  • Tricuspid regurgitation
  • Tricuspid valve surgery
  • Valvular heart disease

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Current Treatment Strategies for Tricuspid Regurgitation'. Together they form a unique fingerprint.

Cite this